Real-time tracking of endogenous CYP2J2 by red-emitting aggregation-induced emission probe with large Stokes shift
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Molecular Sensors and Ion Detection · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Cytochrome P450: genotype to phenotype10.1080/00498254.2019.1648911 ↗
2. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance10.3109/03602532.2013.806537 ↗
3. The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J210.1080/14756366.2021.1896500 ↗
4. Inhibition and inactivation of human CYP2J2: implications in cardiac pathophysiology and opportunities in cancer therapy10.1016/j.bcp.2017.02.017 ↗
5. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme10.1016/j.phymed.2017.12.026 ↗
6. CYP2J2 expression in adult ventricular myocytes protects against reactive oxygen species toxicity10.1124/dmd.117.078840 ↗
7. Cytochrome P450 2J2: potential role in drug metabolism and cardiotoxicity10.1124/dmd.117.078964 ↗
8. Anthracycline derivatives inhibit cardiac CYP2J210.1016/j.jinorgbio.2022.111722 ↗
9. Marmoset cytochrome P450 2J2 mainly expressed in small intestines and livers effectively metabolizes human P450 2J2 probe substrates, astemizole and terfenadine10.3109/00498254.2016.1146366 ↗
10. Regulation of CYP2J2 and EET levels in cardiac disease and diabetes10.3390/ijms19071916 ↗
11. Role of cytochrome P450 2J2 on cell proliferation and resistance to an anticancer agent in hepatocellular carcinoma HepG2 cells
12. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity10.1124/dmd.111.043505 ↗
13. Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine10.1111/j.1365-2125.2001.01292.x ↗
14. Fluorescent probes for the detection and imaging of cytochrome P45010.1016/j.ccr.2020.213740 ↗
15. A ratiometric two-photon fluorescence probe for monitoring mitochondrial HOCl produced during the traumatic brain injury process10.1016/j.snb.2020.127895 ↗
16. Molecular design strategy to construct the near-infrared fluorescent probe for selectively sensing human cytochrome P450 2J210.1021/jacs.8b12136 ↗
17. In situ target enzyme-activated near-infrared fluorescent probe: a case study of CYP2J2 using three-fragmentary molecular assembly engineering10.1016/j.snb.2020.129034 ↗
18. A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes10.1016/j.apsb.2021.11.019 ↗
19. Aggregation-induced emission fluorophores towards the second near-infrared optical windows with suppressed imaging background10.1016/j.ccr.2022.214792 ↗
20. Mitochondria-targeted smart AIEgens: imaging and therapeutics10.1016/j.ccr.2022.214818 ↗
21. AIEgens-lightened functional polymers: synthesis, properties and applications10.1007/s10118-019-2217-0 ↗
22. Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsilole10.1039/b105159h ↗
23. Benzothiadiazole-based dibenzobenzimidazole derivatives with aggregation-induced deep-red fluorescence and different mechanically responsive fluorescence features10.1016/j.dyepig.2022.110580 ↗
24. Tetraphenylethene or triphenylethylene-based luminophors: tunable aggregation-induced emission (AIE), solid-state fluorescence and mechanofluorochromic characteristics10.1016/j.dyepig.2020.108828 ↗
25. Activatable fluorescent probes for in situ imaging of enzymes10.1039/D1CS00543J ↗
26. AIE luminogens as fluorescent bioprobes10.1016/j.trac.2019.115769 ↗
27. Luminescent AIE dots for anticancer photodynamic therapy10.3389/fchem.2021.672917 ↗
28. Aggregation-induced emission luminogens for assisted cancer surgery10.1016/j.ccr.2022.214552 ↗
29. A multifunctional aggregation-induced emission (AIE)-active fluorescent chemosensor for detection of Zn2+ and Hg2+10.1016/j.tet.2019.130489 ↗
30. AIE bioconjugates for biomedical applications10.1002/adom.202000162 ↗
31. Highly bright AIE nanoparticles by regulating the substituent of rhodanine for precise early detection of atherosclerosis and drug screening10.1002/adma.202106994 ↗
32. Aggregation-induced emission: together we shine, united we soar10.1021/acs.chemrev.5b00263 ↗
33. An AIE+TICT activated colorimetric and ratiometric fluorescent sensor for portable, rapid, and selective detection of phosgene10.1016/j.dyepig.2020.108229 ↗
34. An enzyme-activatable probe liberating AIEgens: on-site sensing and long-term tracking of β-galactosidase in ovarian cancer cells10.1039/C8SC04266G ↗
35. Aggregation-induced emission: recent advances in materials and biomedical applications10.1002/anie.202000845 ↗
36. Rational design of near-infrared aggregation-induced-emission-active probes: in situ mapping of amyloid-β plaques with ultrasensitivity and high-fidelity10.1021/jacs.8b12820 ↗
37. Lysosome-targeting red-emitting aggregation-induced emission probe with large Stokes shift for light-up in situ visualization of β-N-acetylhexosaminidase10.1021/acs.analchem.9b03832 ↗
38. A selective and light-up fluorescent probe for β-galactosidase activity detection and imaging in living cells based on an AIE tetraphenylethylene derivative10.1039/C7CC00249A ↗
39. An AIEgen-peptide conjugate as a phototheranostic agent for phagosome-entrapped bacteria10.1002/anie.201906099 ↗
40. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
41. Modulation of erythromycin-induced biochemical responses in crucian carp by ketoconazole10.1007/s11356-016-8268-7 ↗